Keyphrases
Cirrhosis
100%
Portal Hypertension
36%
Inflammatory Bowel Disease
31%
Crohn's Disease
27%
Ulcerative Colitis
22%
Ascites
19%
Hepatorenal Syndrome
16%
Decompensated Cirrhosis
14%
Cirrhotic Patients
13%
Population-based
13%
Hepatic Venous Pressure Gradient
13%
Danish Population
12%
Disease Course
11%
Inception Cohort
11%
Liver
10%
Terlipressin
10%
Cirrhotic Cardiomyopathy
9%
Cardiac Function
9%
Non-alcoholic Fatty Liver Disease (NAFLD)
9%
Inflammation
9%
Beta-blockers
8%
Confidence Interval
8%
Transjugular Intrahepatic Portosystemic Shunt
8%
Cardiac Dysfunction
8%
Liver Cirrhosis
7%
Liver Fibrosis
7%
Hyperdynamic Circulation
7%
Copenhagen
7%
Systematic Meta-analysis
6%
Chronic Pancreatitis
6%
Variceal Bleeding
6%
Nonselective β-blockers
6%
Pathophysiology
6%
Alcoholic Cirrhosis
6%
Acute-on-chronic Liver Failure
6%
Hemodynamic Changes
6%
Propranolol
6%
AIMS™
6%
Disease Severity
6%
Portal Pressure
6%
Liver Transplantation
5%
Renal Function
5%
National Cohort Study
5%
Rifaximin
5%
Bariatric Surgery
5%
Advanced Cirrhosis
5%
Meta-analysis
5%
Cirrhosis Complications
5%
Cardiac Output
5%
Systemic Hemodynamics
5%
Medicine and Dentistry
Liver Cirrhosis
87%
Portal Hypertension
33%
Crohn's Disease
20%
Ulcerative Colitis
18%
Hemodynamic
17%
Ascites
17%
Inflammatory Bowel Disease
15%
Hepatorenal Syndrome
14%
Disease
13%
Cohort Analysis
13%
Disease Course
9%
Heart Function
9%
Venous Pressure
9%
Cirrhotic Cardiomyopathy
9%
Decompensated Liver Cirrhosis
9%
Beta Adrenergic Receptor Blocking Agent
9%
Placebo
8%
Nonalcoholic Fatty Liver
8%
Bleeding
8%
Patient with Inflammatory Bowel Disease
8%
Fibrosis
7%
Inflammatory Bowel Disease
7%
Pathophysiology
6%
Disease Severity
6%
Portal Venous Pressure
6%
Liver Transplantation
6%
Transjugular Intrahepatic Portosystemic Shunt
6%
Liver Disease
5%
Acute on Chronic Liver Failure
5%
Rifaximin
5%
Esophageal Varices
5%
Bariatric Surgery
5%
Patient with Ulcerative Colitis
5%
Tumor Necrosis Factor
5%
Heart Output
5%
Pharmacology, Toxicology and Pharmaceutical Science
Liver Cirrhosis
59%
Portal Hypertension
29%
Inflammatory Bowel Disease
20%
Ulcerative Colitis
20%
Crohn's Disease
16%
Cohort Study
14%
Ascites
11%
Terlipressin
10%
Hepatorenal Syndrome
10%
Inflammation
9%
Disease
9%
Decompensated Liver Cirrhosis
8%
Placebo
8%
Beta Adrenergic Receptor Blocking Agent
8%
Disease Course
8%
Bleeding
8%
Cardiomyopathy
7%
Fibrosis
7%
Remission
6%
Liver Disease
6%
Acute on Chronic Liver Failure
6%
Liver Fibrosis
6%
Esophagus Varices
5%
Rifaximin
5%
Pathophysiology
5%
